2′-Ribose-modified nucleotides: A strategy for reducing off-target effects of oligonucleotide drugs

This publication has 60 references indexed in Scilit:

• Design and systematic evaluation of novel chemical modification patterns enable the identification of a potent siRNA targeting PCSK9
  Molecular Therapy - Methods & Clinical Development, 2025
• Oligonucleotides: evolution and innovation
  Medicinal Chemistry Research, 2024
• A cell-penetrating peptide enhances delivery and efficacy of phosphorodiamidate morpholino oligomers in mdx mice
  Molecular Therapy Nucleic Acids, 2022
• The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer
  Journal of Lipid Research, 2021
• Introducing an In Vitro Liver Stability Assay Capable of Predicting the In Vivo Pharmacodynamic Efficacy of siRNAs for IVIVC
  Molecular Therapy Nucleic Acids, 2020
• In vitro metabolism of 2′‐ribose unmodified and modified phosphorothioate oligonucleotide therapeutics using liquid chromatography mass spectrometry
  Biomedical Chromatography, 2020
• Evaluation and control of miRNA-like off-target repression for RNA interference
  Cellular and Molecular Life Sciences, 2017
• Enhancement of Stability and Activity of siRNA by Terminal Substitution with Serinol Nucleic Acid (SNA)
  ChemBioChem, 2014
• 2′‐Deoxy‐2′‐α‐C‐(hydroxymethyl)adenosine as Potential anti‐HCV Agent
  European Journal of Organic Chemistry, 2011
• Human Argonaute2 Mediates RNA Cleavage Targeted by miRNAs and siRNAs
  Cell, 2004